Eichenfield, Lawrence F. http://orcid.org/0000-0002-2760-0474
Stripling, Stephen
Fung, Selwyn
Cha, Amy
O’Brien, Andryann
Schachner, Lawrence A.
Funding for this research was provided by:
Pfizer
Article History
Accepted: 8 March 2022
First Online: 13 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Pfizer Inc.
: LFE has served as a scientific adviser, consultant, and/or clinical study investigator for Pfizer Inc., AbbVie, Almirall, Amgen, Asana Biosciences, Cutanea, Dermavant, Dermira, Dr. Reddy’s Laboratory, DS Biopharma, Eli Lilly, Forté Pharma, Galderma, Glenmark, Incyte, LEO Pharma, Matrisys Bioscience, Novan, Novartis, Ortho Dermatologics/Valeant, Sanofi Regeneron, Sanofi Genzyme, TopMD, UCB, and Verrica. SS has served as a scientific adviser, consultant, and/or clinical study investigator for Pfizer Inc. SF, AC, and AOB are employees of and own stock in Pfizer, Inc. LAS has served as a scientific advisor, consultant, lecturer and/or on advisory boards for Pfizer, Mustela, CeraVe, Sanofi-Regeneron, Hoth, Alphyn, TopMD, and Verrica.
: All authors made substantial contributions to the conception or design of the work, revised it critically for important intellectual content, approved the version to be published, and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.